Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC

Panel Discussion: What Would Be Your Treatment Decision?

Date

14 Sep 2024

Session

Bristol Myers Squibb - Evolving Patient-Centered Therapies for Metastatic NSCLC

Topics

Patient Education and Advocacy;  Targeted Therapy;  Immunotherapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Jarushka Naidoo, Luis Paz-Ares, Terri Conneran, Alexander Drilon

Authors

J. Naidoo1, L.G. Paz-Ares2, T.D. Conneran3, A.E. Drilon4

Author affiliations

  • 1 Oncology Dept., Beaumont Hospital, D09 FT51 - Dublin/IE
  • 2 Medical Oncology Department - Edificio Maternidad 2ª Planta, Hospital Universitario 12 de Octubre, 28041 - Madrid/ES
  • 3 Patient Advocacy Department, KRAS Kickers, 28277 - Charlotte/US
  • 4 Medicine Department, Memorial Sloan Kettering Evelyn H. Lauder Breast Center, 10065 - New York/US

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.